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Case Report
Myelolipomas of Both Adrenal Glands
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Department of Urology, Chonbuk National University Medical School, Jeonju, Korea
Adrenal myelolipoma is a rare, nonfunctional benign tumor that is composed of mature 
adipose tissue and hematopoietic elements. In the past, these tumors were accidentally 
discovered at autopsy. Today, they are found much more frequently and incidentally, 
mainly because of the widespread use of noninvasive imaging with ultrasonography, 
computed tomography, and magnetic resonance imaging. Most lesions are asympto-
matic, small, and unilateral, but a number of bilateral tumors have been reported. We 
report here on a case of a 48-year-old man with incidentally found myelolipomas of both 
adrenal glands. In particular, a giant myelolipoma of the left adrenal gland was treated 
by transperitoneal laparoscopic adrenalectomy.
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Adrenal myelolipoma is a rare, nonfunctional benign tu-
mor that is composed of mature adipose tissue and hema-
topoietic elements. The tumor was first described by 
Gierke in 1905, and the term myelolipoma was coined by 
Oberling in 1929 [1]. In the past, these tumors were acci-
dentally discovered at autopsy, with an incidence ranging 
from 0.08% to 0.4% [2]. Today, with the widespread use of 
noninvasive imaging with ultrasonography, computed to-
mography (CT), and magnetic resonance imaging (MRI), 
incidental detection of myelolipoma has become more com-
mon, constituting up to 10% to 15% of incidental adrenal 
masses [3]. Most lesions are generally small, unilateral, 
and asymptomatic; nevertheless, a number of bilateral tu-
mors have been described in the literature [4]. We report 
here on a case of incidentally found myelolipomas of both 
adrenal glands. 
CASE REPORT
A 48-year-old man was incidentally detected as having a 
well-defined, heterogeneous enhancing soft tissue density 
lesion in the bilateral retroperitoneum. The lesions were 
found during CT while the patient was undergoing evalua-
tion for a gallbladder polyp that was incidentally detected 
on ultrasonography. The CT showed bilateral masses in 
the anatomical position of the adrenal glands with den-
sities indicating adipose tissue. The maximum diameter 
was 8.0 cm for the left mass and 1.8 cm for the right mass. 
The right adrenal gland was showing but the left was not 
(Fig. 1). He had a 4-year history of hypertension, for which 
he was receiving antihypertensive medication. He had no 
specific symptoms and the results of a physical examina-
tion were also nonspecific. The biochemistry profile show-
ed an elevated level of plasma epinephrine of 67.8 pg/ml 
(range, 1-20 pg/ml), norepinephrine of 340.8 pg/ml (range, 
15-80 pg/ml), and ACTH of 158 pg/ml (range, 10-90 pg/ml), 
and urinary 17-KS of 48.5 mg/day (range, 8-22 mg/day) and 
17-OHCS of 55 mg/day (range, 5-23 mg/day). Plasma corti-
sol, renin, aldosterone, and 24-hour urinary cortisol, free 
cortisol, metanephrine, vanillylmandelic acid, and homo-
vanillic acid were all within normal limits. In the abdomi-
nal MRI, the left tumor measured 8.2 cm and the right tu-
mor measured 2.0 cm in maximum diameter, had high sig-
nal intensity on both T1- and T2-weighted images, and low 
signal intensity on T1 fat-suppressed images and chem-
ical-shift images (Fig. 2). In the (123) I-metaiodobenzy-
lguanidine (MIBG) scan there was no significant uptake 
region. This suggested the diagnosis of incidental retro-
peritoneal masses, probably a myelolipoma. A differential 
diagnosis for malignant tumors was necessary, so the pa-
tient was subjected to transperitoneal laparoscopic left 
adrenalectomy. On macroscopic examination of the surgi-
cally removed specimen, the tumor was measured as 
9.1x4.9 cm, weighed 128 g, and was yellowish-brown in Korean J Urol 2011;52:582-585
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FIG. 1. The CT scan shows bilateral 
masses in the adrenal glands with 
densities indicating adipose tissue. (A) 
Axial section image. (B) Coronal section
image.
FIG.2. The magnetic resonance imaging
shows the masses having high signal 
intensity on the T2 weighted image (A) 
and low signal intensity on the T1 
fat-suppressed image (B).
FIG. 3. (A) Macroscopic view of the left adrenal myelolipoma. (B) Myelolipoma composed of mature fat mixed with hematopoietic 
element including megakaryocytes. Note the normal adrenal cortical tissue (right) (H&E, x200).
color. Microscopic examination revealed that the tumor 
was composed of mature fat mixed with hematopoietic ele-
ments including megakaryocytes (Fig. 3). These findings 
established the diagnosis of adrenal myelolipoma. There 
was no evidence of malignancy. The patient recovered well 
without any major complications.
DISCUSSION
Myelolipomas are rare, benign tumors composed of mature 
adipose tissue and hematopoietic elements. The adrenal 
gland is the most common site, but myelolipomas are also 
rarely present in extra-adrenal sites, including the pelvis, 
mediastinum, retroperitoneum, and paravertebral region, 
as an isolated soft tissue mass [5]. Adrenal myelolipoma, Korean J Urol 2011;52:582-585
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affecting both sexes in similar rates, usually presents late 
in adult life, and most cases are diagnosed during the fourth 
to seventh decade. The association of myelolipoma with 
obesity, hypertension, chronic disease, and malignancies 
has been described [3].
　Adrenal myelolipomas are in the majority of cases uni-
lateral and often less than 4 cm in diameter. However, they 
may attain very large sizes and also be bilateral. The term 
giant myelolipoma is preferred when the size exceeds 8 cm. 
In the literature, the largest adrenal myelolipoma (diame-
ter 31 cm, weight 6.0 kg) was described by Akamatsu and 
colleagues [6]. To our knowledge, 10 cases of adrenal myelo-
lipoma were reported in Korea. However, these cases were 
all unilateral [7]. Therefore, our case is characterized by the 
presence of bilateral adrenal myelolipomas. 
　Adrenal myelolipoma, which is usually asymptomatic, 
is generally diagnosed during surgical interventions and 
imaging procedures performed for other purposes. Our 
patient also performed CT for evaluation of a gallbladder 
polyp that was incidentally detected on ultrasonography. 
In symptomatic cases, the most common symptom is non-
specific abdominal pain, probably due to hemorrhage, 
tumor necrosis, or mechanical compression of adjacent 
organs from large tumor bulk. Also, hematuria and renova-
scular hypertension were seen. Although rare, surgical 
emergencies such as a retroperitoneal hemorrhage may be 
encountered. 
　Adrenal myelolipomas are generally hormonally in-
active, although there are case reports of their association 
with overproduction of adrenal hormones. They have been 
associated with overproduction of dehydroepiandroster-
one-sulphate (DHEAS), congenital adrenal hyperplasia 
caused by 21-hydroxylase deficiency, congenital adrenal 
17 α-hydroxylase deficiency, Cushing disease, Conn's syn-
drome, adrenal insufficiency, and pheochromocytoma [8]. 
Some of these tumors coexist with adrenal adenomas, 
which may in part account for the hormonal activity. 
Among them, congenital adrenal hyperplasia and Cushing 
syndrome appear to be the two most common endocrine dis-
orders described. In our case, the levels of plasma epi-
nephrine, norepinephrine, and ACTH were elevated, but 
there was no evidence of a functioning pheochromocytoma 
in the MIBG scan or other hormone-producing tumors in 
the histopathology. His hypertension remained after the 
operation, so it was considered essential hypertension.
　The pathogenesis of myelolipoma is uncertain, with the 
prevalent hypothesis suggesting that they arise from the 
zona fasciculate of the adrenal cortex from metaplasia of 
undifferentiated stromal cells [3]. More specifically, they 
are assumed to arise from metaplasia of either previously 
uncommitted adrenal cortical mesenchymal cells or of 
groups of choristomatous hematopoietic stem cells that 
transmigrate during intrauterine life to the developing 
adrenal gland [9]. Other theories, less favored, propose 
embolism of bone marrow cells and development from 
intra-adrenal embryonic rests of bone marrow [9]. 
　Diagnosis of myelolipoma is based on imaging, with ul-
trasonography, CT, and MRI being effective in more than 
90% of cases. The classic myelolipoma is radiolucent on 
plain films and avascular on angiography. On ultra-
sonography, a myelolipoma is hyperechoic if it consists 
mostly of fat and hypoechoic if it is composed primarily of 
myeloid cells. Usually, the lesion has mixed hyperechoic 
and hypoechoic areas. CT is the most sensitive imaging mo-
dality, and the appearance of myelolipoma depends on its 
histological composition. Myelolipoma often has a discrete 
capsule and appears as well-delineated heterogeneous 
masses with regions of less than −30 Hounsfield units that 
correspond to low-density mature fat. In MRI, fat tissue has 
high signal intensity in both T1 and T2 images, whereas 
myeloid tissue has low signal intensity in T1 and moderate 
signal intensity in T2 images [10]. Differential diagnosis 
includes other fat-containing adrenal masses such as ter-
atoma, lipoma, and liposarcoma, which are less common, 
and even rarely angiomyolipoma, mass-forming extra-
medullary hematopoiesis, and adenoma. In case a diag-
nosis has not been established, fine needle aspiration can 
be helpful to definitively rule out malignancy.
　Previously, most patients with myelolipoma underwent 
surgical resection for a suspected malignant neoplasm. 
Nowadays, with the frequent detection of these myelolipo-
mas incidentally, the treatment has been a matter of much 
debate. When the tumor is 4 cm or smaller and asympto-
matic, follow-up with CT is recommended. If symptoms oc-
cur, surgery should be carried out promptly, especially for 
a large myelolipoma, because spontaneous rupture of the 
lesion with hemorrhage is possible. If laparoscopic ex-
pertise is available, then the excision is done laparosco-
pically. Previously, a tumor size exceeding 5 to 6 cm was 
thought to be a contraindication for the laparoscopic 
approach. But several recent studies have shown that the 
laparoscopic approach is technically feasible, safe, and 
comparable with the open approach in these patients. In 
the case of bilateral adrenal myelolipomas, a staged tumor 
removal is preferable, removing the larger one and con-
tinuing to observe the contralateral myelolipoma as long 
as possible in an effort to avoid adrenal insufficiency and 
a lifetime of steroid replacement [3]. Our patient had bi-
lateral adrenal myelolipomas in which the left tumor was 
larger than the right, measuring 8.2 cm vs. 2.0 cm in max-
imum diameter on the MRI. The patient underwent trans-
peritoneal laparoscopic left adrenalectomy. However, if 
there were bilateral, giant, symptomatic adrenal myeloli-
pomas in a patient with congenital adrenal hyperplasia, 
bilateral surgical resection should be done.
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